PNR1- COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS OF INTERFERON BETA-IB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN POLAND (2-YEARS PERSPECTIVE)
Sep 1, 2000, 00:00
10.1016/S1098-3015(11)70789-6
https://www.valueinhealthjournal.com/article/S1098-3015(11)70789-6/fulltext
Title :
PNR1- COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS OF INTERFERON BETA-IB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN POLAND (2-YEARS PERSPECTIVE)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70789-6&doi=10.1016/S1098-3015(11)70789-6
First page :
Section Title :
Open access? :
No
Section Order :
172